Shatavari (Expanded) for Immune Function

Research suggests that Shatavari (Asparagus racemosus) demonstrates consistent immunomodulatory activity across a broad range of preclinical study designs, with evidence pointing to multiple mechanisms including enhanced T cell populations, upregulated Th1 and Th2 cytokine profiles, improved antibody production, heightened natural killer cell activity, and protection against chemotherapy-induced immune suppression. Studies indicate that several constituents, particularly the saponin fractions and fructo-oligosaccharides, appear to contribute to these effects, with saponins also showing potential as vaccine adjuvants in animal models. The body of evidence is composed almost entirely of animal studies, in vitro experiments, and computational analyses, with only limited human or randomized controlled trial data, meaning findings cannot yet be reliably extrapolated to human immune health outcomes. The overall direction of the research is consistently supportive, but the absence of robust clinical trials in humans represents a significant limitation that warrants caution in drawing firm conclusions.